β2-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface

Thrombosis and Haemostasis

Volumn 75, Issue 1, 1996, Pages 49-55

  Mori, Tatsuyuki ^a   Takeya, Hiroyuki ^a   Nishioka, Junji ^a   Gabazza, Esteban C ^a   Suzuki, Koji ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; PHOSPHOLIPID; PROTEIN S; VIPER VENOM;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0030048935     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650220     Document Type: Article

References (46)

1. 2-glycoprotein-I to human serum lipoproteins - distribution among density fractions. FEBS Lett 1979; 102: 183-6.
2. 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-5.
3. 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66: 1086-91.
4. 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation. Thromb Haemost 1985; 54: 397-401.
5. 2-glycoprotein-I. Biochim Biophys Acta 1986; 884: 142-9.
6. 2-Glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 1992; 67; 649-53.
7. Triplett DA. Antiphospholipid antibodies and thrombosis - a consequence, coincidence, or cause? Arch Pathol Lab Med 1993; 117: 78-88.
8. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994; 84: 2854-67.
9. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
10. 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89: 397-402.
11. 2-glycoprotein I is potentiated by a distinct subgroup of anti-cardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
12. Suzuki K. Protein C. In: Molecular basis of thrombosis and hemostasis. High KA, Roberts HR, eds. Marcel Dekker, Inc., New York, 1995; pp 393-424.
13. Suzuki K. Protein S. In: Molecular basis of thrombosis and hemostasis. High KA, Roberts HR, eds. Marcel Dekker, Inc., New York, 1995, pp 459-478.
14. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-80.
15. 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro. J Clin Pathol 1993; 46: 908-11.
16. Walker FJ. Does beta-2-glycoprotein I inhibit the interaction between protein S and C4b-binding protein? Thromb Haemost 1993 (abstr); 69: 930.
17. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62.
18. Miletich JP, Broze GJ, Majerus PW. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem 1980; 105: 304-10.
19. Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-20.
20. Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-46.
21. Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 1983; 209: 847-56.
22. Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-64.
23. DiScipio RG, Hermodson MA, Davic EW. Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. Biochemistry 1977; 16: 5253-60.
24. Iino M, Takeya H, Nishioka J, Nakagaki T, Tamura K, Suzuki K. The role of human factor X activation peptide in activation of factor X by factor IXa. J Biochem 1994; 116: 335-40.
25. Suzuki K, Nishioka J, Hashimoto S. Regulation of activated protein C by thrombin-modified protein S. J Biochem 1983; 94. 699-705.
26. DiScipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 1977; 16: 698-706.
27. Dahlbäck B. Human coagulation factor V purification and thrombin-catalyzed activation. J Clin Invest 1980; 66: 583-91.
28. De Frutos PG, Alim RIM, Härdig Y, Zöller B, Dahlbäck B. Differential regulation of α and β chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-22.
29. Suzuki K, Nishioka J. Binding site for vitamin K-dependent protein S on complement C4b-binding protein. J Biol Chem 1988; 263: 17034-9.
30. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S-Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 1994; 83: 683-90.
31. Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269: 816-9.
32. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell's viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-74.
33. Nelson RM, Long GL. Solution-phase equilibrium binding interaction of human protein S with C4b-binding protein. Biochemistry 1991; 30: 2384-90.
34. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-77.
35. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91: 2728-32.
36. 155→Glu) for the regulation of the blood coagulation system. Biochim Biophys Acta 1995; (in press).
37. 2-glycoprotein I. Thromb Haemost 1992; 67: 499-502.
38. 2-glycoprotein I. J Clin Invest 1992, 90: 1100-4.
39. 2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemost 1993; 70: 342-5.
40. 2-Glycoprotein I and anticardiolipin antibody influence factor Xa generation but not factor Xa binding to platelet-derived microparticles Thromb Haemost 1994; 71: 526-30.
41. 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation. Thromb Haemost 1991; 66: 666-71.
42. 2-Glycoprotein-I-dependent lupus anticoagulant activity is inhibited by hexagonal (II) phase phospholipid. Arthritis Rheum 1992; 35 (abstr): S69.
43. Kostetskii E, Gerasimenko NI, Kushnerova NF. The phospholipid composition of organs and tissues of rabbit. Biokhimiia 1977; 42: 671-6.
44. 2-glycoprotein I in its interaction with cardiolipin. J Biochem 1995; 118: 129-36.
45. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous tbromboembolism. Blood 1995; 85: 607-14.
46. Bokarewa MI, Blombäck M, Rosén NES. A new variant of interaction between phospholipid antibodies and the protein C system. Blood Coag Fibrinol 1994; 5: 37-41.